Enzalutamide
9785-CL-0336
Phase 3 small_molecule active
Quick answer
Enzalutamide for Metastatic Hormone Sensitive Prostate Cancer is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Metastatic Hormone Sensitive Prostate Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active